Ticagrelor patient counseling information

Revision as of 23:43, 27 February 2014 by Jesus Hernandez (talk | contribs) (Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Patient Counseling Information== See FDA-approved patient labeling (Medication Guide) ===Benefits and Risks=== * Tell pat...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]

Patient Counseling Information

See FDA-approved patient labeling (Medication Guide)

Benefits and Risks

  • Tell patients to take BRILINTA exactly as prescribed.
  • Inform patients not to discontinue BRILINTA without discussing it with the prescribing physician.
  • Tell patients daily doses of aspirin should not exceed 100 mg and to avoid taking any other medications that contain aspirin.
  • Tell patients to read the Medication Guide.

Bleeding

Inform patients that they:

  • Will bleed and bruise more easily
  • Will take longer than usual to stop bleeding
  • Should report any unanticipated, prolonged or excessive bleeding, or blood in their stool or urine.

Other Signs and Symptoms Requiring Medical Attention

  • Inform patients that BRILINTA can cause shortness of breath.
  • Tell them to contact their doctor if they experience unexpected shortness of breath, especially if severe.

Invasive Procedures

Instruct patients to:

  • Inform physicians and dentists that they are taking BRILINTA before any surgery or dental procedure.
  • Tell the doctor performing any surgery or dental procedure to talk to the prescribing physician before stopping BRILINTA.

Concomitant Medications

  • Tell patients to list all prescription medications, over-the-counter medications or dietary supplements they are taking or plan to take so the physician knows about other treatments that may affect bleeding risk (e.g. warfarin, heparin). [1]


References

[1]

  1. 1.0 1.1 "BRILINTA (TICAGRELOR) TABLET [ASTRAZENECA LP]". Retrieved 26 February 2014.